rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jeffrey Del Carmen

Chief Commercial Officer

Company insider

Files Form 4 as: Chief Commercial Officer, Catalyst Pharmaceutical.

Every Form 4 they filed

In numbers

Trades disclosed
91
Buys
0
Sells
7
Bought
$0
Sold
$4.8M
Companies
1
Companies where not an officer
0
First trade
30 Dec 2020
Last trade
15 Jul 2026
Last filed
17 Jul 2026

Companies traded

Where they are an officer
Catalyst PharmaceuticalOfficer · Biotechnology · last 15 Jul 20260 buys · 7 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jul 2026filed 17 Jul 2026Catalyst PharmaceuticalBiotechnologySEC FORM 4 Code D$452K14,337 at $31.50filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—11,206 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—32,257 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—150,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—200,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—150,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—200,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—135,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—88,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—167,918 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—137,553 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—106,873 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—8,039 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—11,206 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—32,257 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—135,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—88,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—167,918 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—137,553 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—106,873 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed7

Buys in green, sells in red, by the company’s sector.

Related people

Patrick J. McEnanyDirector and Other role · Director and Other at Catalyst Pharmaceuticals, filing Form 4 there in the last year
Donald A. DenkhausDirector · Director at Catalyst Pharmaceuticals, filing Form 4 there in the last year
David S. TierneyDirector · Director at Catalyst Pharmaceuticals, filing Form 4 there in the last year
Steve MillerChief Op. & Scientific Officer · Chief Op. & Scientific Officer at Catalyst Pharmaceuticals, filing Form 4 there in the last year
Richard J. DalyPresident and CEO · President and CEO at Catalyst Pharmaceuticals, filing Form 4 there in the last year